Oh, So That's Who Signed Off on the FBI Spy Operation Into the...
Chuck Schumer Is About to Be Taken Behind the Barn Over This Tweet
Watch Trump Roast a Reporter Over This Silly Question About the East Room...
Trump Just Called Off Planned Immigration 'Surge' In This City – for Now
Trump Administration Is Preparing Unprecedented Action Against Drug Cartels
Nancy Pelosi Just Made a Serious Threat Against ICE Agents
Some Democrats Are Sour on Mandela Barnes Running for Wisconsin Governor
Vance Bridges Faith and Diplomacy: Visits Church of the Holy Sepulchre Amid Peace...
Famous Berlin Drag Queen Under Investigation for Child Porn
NJ Democrat Councilman Calls ICE an 'Invasive Species,' Says Agency Should Be Eliminated
Anti-ICE Protestor Who Called for Violence a 'Human Rights Award' Winner
Vance Claps Back After Jen Psaki's Comments Regarding His Wife
NYC Gubernatorial Candidates Trade Blows Over Scandals in Heated Exchange
Jack Smith Justifies His Secret Subpoenas, Republicans Aren’t Buying It
Stephen Miller Torches Robert De Niro After Nazi Smear on MSNBC
Tipsheet

There Are Now Three Coronavirus Vaccines Approved by the FDA

AP Photo/Tsafrir Abayov

The Trump era's Operation Warp Speed is the gift that keeps on giving. On Saturday, the Food and Drug Administration (FDA) approved Johnson & Johnson's Wuhan coronavirus vaccine, making it the third coronavirus vaccine approved in the United States. 

Advertisement

The agency's emergency-use approval comes one day after an advisory panel for the FDA recommended drugmaker Johnson & Johnson's vaccine candidate for approval. 

Johnson & Johnson's vaccine is the third coronavirus vaccine to receive FDA approval, but the first vaccine requiring just one shot for vaccination. The drug showed a 66 percent effectiveness against moderate to severe COVID-19 infections and about an 85 percent effectiveness against the most serious illnesses. While two other FDA-approved vaccines have efficacy rates in the 90s, Johnson & Johnson's drug was shown to prevent 100 percent of hospitalizations in a clinical study of around 44,000 participants in the United States. 

"This is a vaccine to prevent you from going to the hospital and dying at a level that’s certainly comparable" to the Pfizer and Moderna vaccines, said Dr. Paul Offit, a member of the FDA's advisory panel and vaccine expert at Children's Hospital of Philadelphia.

Advertisement

Unlike the vaccines developed by Pfizer and Moderna, Johnson & Johnson's vaccine candidate does not to be stored in freezers and remains stable for months in refrigerated temperatures.  

Around 3 to 4 million doses of the new vaccine are expected to be shipped out as early as next week. The company has pledged to deliver some 20 million doses by April and 100 million by late June.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement